Myriad Genetics Third Quarter 2025 Financial Earnings

11/03/2025 | 1:30pm PT / 4:30pm ET

Webcast link
Download Presentation

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
11/04/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/04/2025 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
11/04/2025 8-K/A Amendment to a previously filed 8-K RTF XLS PDF HTML XBRL
11/03/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
10/31/2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
10/24/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
10/07/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
10/03/2025 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
09/22/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/22/2025 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution (as corrected) Thumbnail

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution (as corrected)

Nov 03, 2025 | Corporate | Financial

Read more
New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner Thumbnail

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

Oct 31, 2025 | Products

Read more
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 Thumbnail

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Oct 27, 2025 | Financial | Corporate

Read more
View all news releases

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Read our QICR report